Newsletter September 2016 No. 175
Top News
The "Kotto Policy 2016" was discussed.
On June 2, 2016, the Cabinet approved the "Basic Policies for Economic and Fiscal Management and Reform 2016" (the so-called "Kotta Policy 2016"). This paper outlines some of the areas that are expected to have a relatively large impact on the pharmaceutical industry.
Topics
- The 2nd "ICH Lisbon Conference" was held.
- Resumed public-private mission to China and dispatched a delegation to China
- The 1st Japan-Korea Symposium on Medical Product Regulation" was held.
- Isao Teshirogi (President, Shionogi & Co., Ltd.) was elected as the new Vice President of IFPMA at the IFPMA Board Meeting.
- Held the 2016 Seminar on Countermeasures against Counterfeit Medicines
- Safety and Health Technical Workshop
Connecting with Citizens and Patients
Policy Research Institute
Clinical Development and Review Period of New Drugs -2015 Results
From JPMA
Toward the Realization of a "World-leading Health Nation